{"id":"https://openalex.org/W7214683046","doi":"https://doi.org/10.64898/2026.09.26.26363761","title":"No Heavy Drinking Days and Percentage of Days Abstinent in a Randomized Trial of Adjunctive Ketamine for Alcohol Use Disorder: Secondary Analysis of the KARE Trial","display_name":"No Heavy Drinking Days and Percentage of Days Abstinent in a Randomized Trial of Adjunctive Ketamine for Alcohol Use Disorder: Secondary Analysis of the KARE Trial","publication_year":2026,"publication_date":"2026-09-28","ids":{"openalex":"https://openalex.org/W7214683046","doi":"https://doi.org/10.64898/2026.09.26.26363761"},"language":"en","primary_location":{"id":"doi:10.64898/2026.09.26.26363761","doi":"https://doi.org/10.64898/2026.09.26.26363761","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.26.26363761","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/28/2026.09.26.26363761.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/28/2026.09.26.26363761.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058235132","display_name":"Celia J. A. Morgan","orcid":"https://orcid.org/0000-0002-8858-4906","observed_orcids":["https://orcid.org/0000-0002-8858-4906"]},"institutions":[{"id":"https://openalex.org/I23923803","display_name":"University of Exeter","ror":"https://ror.org/03yghzc09","country_code":"GB","type":"education","lineage":["https://openalex.org/I23923803"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Celia JA Morgan","raw_affiliation_strings":["Department of Psychology, University of Exeter, Exeter, UK"],"raw_orcid":"https://orcid.org/0000-0002-8858-4906","affiliations":[{"raw_affiliation_string":"Department of Psychology, University of Exeter, Exeter, UK","institution_ids":["https://openalex.org/I23923803"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016082897","display_name":"David Nutt","orcid":"https://orcid.org/0000-0002-1286-1401","observed_orcids":["https://orcid.org/0000-0002-1286-1401","https://orcid.org/0000-0002-6423-9411"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David J. Nutt","raw_affiliation_strings":["Division of Psychiatry, Imperial College London, London, UK and Solvonis Therapeutics"],"raw_orcid":"https://orcid.org/0000-0002-1286-1401","affiliations":[{"raw_affiliation_string":"Division of Psychiatry, Imperial College London, London, UK and Solvonis Therapeutics","institution_ids":["https://openalex.org/I47508984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5058235132"],"corresponding_institution_ids":["https://openalex.org/I23923803"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11207","display_name":"Alcohol Consumption and Health Effects","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ketamine","display_name":"ketamine","score":0.824999988079071},{"id":"https://openalex.org/keywords/alcoholism","display_name":"alcoholism","score":0.972000002861023},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.6299999952316284},{"id":"https://openalex.org/keywords/heavy-drinking-days","display_name":"heavy drinking days","score":0.9279999732971191},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":0.8119999766349792},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.9750000238418579},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":1.0},{"id":"https://openalex.org/keywords/post-hoc-analysis","display_name":"post hoc analysis","score":0.47699999809265137},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.39899998903274536}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7775999903678894},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6486999988555908},{"id":"https://openalex.org/C2780795376","wikidata":"https://www.wikidata.org/wiki/Q243547","display_name":"Ketamine","level":2,"score":0.5964999794960022},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5006999969482422},{"id":"https://openalex.org/C2781066024","wikidata":"https://www.wikidata.org/wiki/Q156","display_name":"Alcohol","level":2,"score":0.46209999918937683},{"id":"https://openalex.org/C2780477327","wikidata":"https://www.wikidata.org/wiki/Q2115980","display_name":"Psychoeducation","level":3,"score":0.4564000070095062},{"id":"https://openalex.org/C3017483375","wikidata":"https://www.wikidata.org/wiki/Q15326","display_name":"Heavy drinking","level":4,"score":0.4343000054359436},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.38920000195503235},{"id":"https://openalex.org/C2779436514","wikidata":"https://www.wikidata.org/wiki/Q4713263","display_name":"Alcohol dependence","level":3,"score":0.34470000863075256},{"id":"https://openalex.org/C3018162438","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Adjunctive treatment","level":2,"score":0.3296000063419342},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3237999975681305},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.3061999976634979},{"id":"https://openalex.org/C3018023364","wikidata":"https://www.wikidata.org/wiki/Q425265","display_name":"Significant difference","level":2,"score":0.30000001192092896},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.28540000319480896},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.27480000257492065},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26019999384880066}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.09.26.26363761","doi":"https://doi.org/10.64898/2026.09.26.26363761","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.26.26363761","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/28/2026.09.26.26363761.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.09.26.26363761","doi":"https://doi.org/10.64898/2026.09.26.26363761","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.26.26363761","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/28/2026.09.26.26363761.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214683046.pdf","grobid_xml":"https://content.openalex.org/works/W7214683046.grobid-xml"},"referenced_works_count":1,"referenced_works":["https://openalex.org/W7160062099"],"related_works":["https://openalex.org/W4206344419","https://openalex.org/W7129021116","https://openalex.org/W4226265235","https://openalex.org/W7214794305","https://openalex.org/W2991597523","https://openalex.org/W2998452567","https://openalex.org/W2604340903","https://openalex.org/W4401695468","https://openalex.org/W4367184015","https://openalex.org/W3007863987"],"abstract_inverted_index":{"Abstract":[0],"In":[1],"the":[2,45,55,84],"KARE":[3],"trial,":[4],"96":[5],"adults":[6],"with":[7,34],"severe":[8],"alcohol":[9,40],"use":[10],"disorder,":[11],"abstinent":[12,73],"following":[13],"detoxification,":[14],"were":[15,116],"randomised":[16],"in":[17,112,118],"a":[18,143],"2\u00d72":[19],"factorial":[20],"design":[21],"to":[22,51,139,152],"3":[23],"weekly":[24],"infusions":[25],"of":[26,149],"ketamine":[27,65],"(0.8":[28],"mg/kg)":[29],"or":[30,39],"saline,":[31],"each":[32],"combined":[33],"mindfulness-based":[35],"psychological":[36],"support":[37],"(PS)":[38],"psychoeducation":[41],"(PE).":[42],"We":[43],"re-expressed":[44],"trial":[46],"data":[47],"on":[48],"endpoints":[49],"acceptable":[50],"regulators":[52],"and":[53,57,124,131],"compared":[54],"most":[56],"least":[58],"intensive":[59],"arms.":[60],"Across":[61],"pooled":[62],"weeks":[63,87,97],"17\u201324,":[64],"plus":[66],"PS":[67],"gave":[68],"78.5%":[69],"versus":[70,100],"57.8%":[71],"days":[72,106,115],"(difference,":[74],"20.7":[75],"percentage":[76,91],"points;":[77],"P":[78],"=":[79,94,108],".032);":[80],"adjusted":[81],"for":[82,127],"baseline,":[83],"difference":[85],"at":[86],"21\u201324":[88],"was":[89],"26.9":[90],"points":[92],"(P":[93,107],".011).":[95],"At":[96],"21\u201324,":[98],"50.0%":[99],"26.1%":[101],"had":[102],"no":[103],"heavy":[104,113],"drinking":[105,114],".127).":[109],"Relative":[110],"reductions":[111],"55%":[117],"KARE,":[119],"against":[120],"25%,":[121],"\u221217%,":[122],"46%":[123],"35%":[125],"reported":[126],"naltrexone,":[128],"exenatide,":[129],"semaglutide":[130],"pemvidutide.":[132],"These":[133],"post":[134],"hoc":[135],"differences,":[136],"measured":[137],"4":[138,144],"6":[140],"months":[141],"after":[142],"week":[145],"course":[146],"ended,":[147],"are":[148],"magnitude":[150],"similar":[151],"agents":[153],"requiring":[154],"continuous":[155],"administration.":[156]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-09-29T00:00:00"}